Bilateral Breast Cancer disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: BLT006 MIFTS: 48	Bilateral Breast Cancer Categories: Cancer diseases
Genes Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Bilateral Breast Cancer

MalaCards integrated aliases for Bilateral Breast Cancer:

Name: Bilateral Breast Cancer ¹² ⁵⁵ ¹⁵ ⁷³

Bilateral Breast Carcinoma ¹² ²⁹ ⁶

Classifications:

MalaCards categories:
Global: Cancer diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:6741

NCIt ⁵⁰ C8287

UMLS ⁷³ C0281267

Sources

Summaries for Bilateral Breast Cancer

Disease Ontology : ¹² A breast carcinoma that is characterized by an individual having breast cancer in both breasts, either simultaneously or at different times.

MalaCards based summary : Bilateral Breast Cancer, also known as bilateral breast carcinoma, is related to synchronous bilateral breast carcinoma and ataxia-telangiectasia. An important gene associated with Bilateral Breast Cancer is BRCA1 (BRCA1, DNA Repair Associated), and among its related pathways/superpathways are Gene Expression and Cell Cycle, Mitotic. The drugs Anastrozole and Exemestane have been mentioned in the context of this disorder. Affiliated tissues include breast, bone and prostate, and related phenotypes are Decreased homologous recombination repair frequency and Decreased homologous recombination repair frequency

Sources

Related Diseases for Bilateral Breast Cancer

Diseases related to Bilateral Breast Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)

#	Related Disease	Score	Top Affiliating Genes
1	synchronous bilateral breast carcinoma	31.5	ATM BRCA1 BRCA2 ESR1 PGR
2	ataxia-telangiectasia	29.7	ATM BRCA1 CHEK2
3	papillary serous adenocarcinoma	29.5	BRCA1 PGR
4	li-fraumeni syndrome	29.2	ATM BRCA1 BRCA2 CHEK2
5	breast squamous cell carcinoma	29.0	ERBB2 PGR
6	gynecomastia	28.5	ESR1 PGR
7	prostate cancer	27.8	BRCA1 BRCA2 CHEK2 ERBB2 ESR1
8	ductal carcinoma in situ	27.1	BRCA1 BRCA2 ERBB2 ESR1 PGR
9	ovarian cancer	25.7	ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
10	breast cancer	25.6	ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
11	sporadic breast cancer	24.0	ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
12	hereditary site-specific ovarian cancer syndrome	10.8	BRCA1 BRCA2
13	breast reconstruction	10.7	BRCA1 BRCA2
14	breast-ovarian cancer, familial 1	10.7	BRCA1 BRCA2
15	peritoneum cancer	10.7	BRCA1 BRCA2
16	premature menopause	10.6	BRCA1 BRCA2
17	clear cell adenofibroma	10.6	BRCA1 BRCA2
18	cystadenofibroma	10.6	BRCA1 BRCA2
19	lynch syndrome i	10.5	BRCA1 BRCA2
20	fanconi anemia, complementation group d2	10.5	BRCA2 RAD51
21	myxosarcoma	10.5	ATM BRCA1
22	mutagen sensitivity	10.4	BRCA1 BRCA2
23	breast giant fibroadenoma	10.4	BRCA2 ESR1
24	nijmegen breakage syndrome	10.2	ATM BRCA1 CHEK2
25	t-cell prolymphocytic leukemia	10.2	ATM CHEK2
26	congenital hypoplastic anemia	10.2	BRCA2 RAD51
27	comedo carcinoma	10.1	ERBB2 ESR1
28	tuberculous salpingitis	10.0	BRCA1 BRCA2 ERBB2
29	uterine corpus serous adenocarcinoma	10.0	BRCA1 BRCA2 ERBB2
30	fallopian tube adenocarcinoma	10.0	BRCA1 BRCA2 ERBB2
31	ovarian cancer 1	10.0	BRCA1 BRCA2 ERBB2
32	aging	10.0
33	corneal abscess	9.9	PGR RAD51
34	hidradenocarcinoma	9.9	ERBB2 ESR1
35	vulvar syringoma	9.9	ESR1 PGR
36	lung leiomyoma	9.9	ESR1 PGR
37	vestibular gland benign neoplasm	9.9	ESR1 PGR
38	bartholin's gland adenoma	9.9	ESR1 PGR
39	vulvar benign neoplasm	9.9	ESR1 PGR
40	trigonitis	9.9	ESR1 PGR
41	vulvar leiomyoma	9.9	ESR1 PGR
42	predominantly cortical thymoma	9.9	ESR1 PGR
43	progesterone resistance	9.9	ESR1 PGR
44	cribriform carcinoma	9.9	ESR1 PGR
45	endometrial squamous cell carcinoma	9.9	ESR1 PGR
46	gastric signet ring cell adenocarcinoma	9.9	ESR1 PGR
47	endometrial mucinous adenocarcinoma	9.9	ESR1 PGR
48	adenoid basal cell carcinoma	9.9	ESR1 PGR
49	gender identity disorder	9.9	ESR1 PGR
50	bartholin's gland benign neoplasm	9.9	ESR1 PGR

Graphical network of the top 20 diseases related to Bilateral Breast Cancer:

Sources

Symptoms & Phenotypes for Bilateral Breast Cancer

GenomeRNAi Phenotypes related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

²⁶ (show all 19)

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased homologous recombination repair frequency	GR00151-A-1	10.59	RAD51 BRCA1
2	Decreased homologous recombination repair frequency	GR00151-A-2	10.59	RAD51 BRCA1
3	Decreased homologous recombination repair frequency	GR00236-A-1	10.59	RAD51 PGR BRCA1 BRCA2
4	Decreased homologous recombination repair frequency	GR00236-A-2	10.59	RAD51 PGR BRCA1 ATM BRCA2
5	Decreased homologous recombination repair frequency	GR00236-A-3	10.59	RAD51 BRCA1 BRCA2
6	Decreased viability	GR00221-A-1	10.58	ESR1
7	Decreased viability	GR00221-A-2	10.58	ESR1 CHEK2 BRCA1
8	Decreased viability	GR00221-A-3	10.58	ERBB2 CHEK2 BRCA1 ATM
9	Decreased viability	GR00221-A-4	10.58	ERBB2 ESR1 CHEK2 ATM
10	Decreased viability	GR00301-A	10.58	BRCA1
11	Decreased viability	GR00342-S-2	10.58	CHEK2
12	Decreased viability	GR00402-S-2	10.58	ERBB2 ESR1 CHEK2 BRCA1 ATM
13	Decreased viability in esophageal squamous lineage	GR00235-A	9.87	CHEK2 ERBB2 ESR1 PGR RAD51 BRCA1
14	Increased viability with MLN4924 (a NAE inhibitor)	GR00250-A-3	9.55	RAD51 BRCA1 ATM BRCA2 CHEK2
15	Decreased viability after ionizing radiation	GR00232-A-2	9.54	BRCA1 ATM BRCA2
16	Decreased viability with cisplatin	GR00101-A-4	9.43	RAD51 BRCA2 BRCA1
17	Synthetic lethal with MLN4924 (a NAE inhibitor)	GR00250-A-1	9.28	CHEK2 BRCA1 ATM BRCA2
18	Synthetic lethal with MLN4924 (a NAE inhibitor)	GR00250-A-2	9.28	RAD51 CHEK2 BRCA1 ATM BRCA2
19	Synthetic lethal with cisplatin	GR00101-A-1	9.13	RAD51 BRCA2 BRCA1

MGI Mouse Phenotypes related to Bilateral Breast Cancer:

⁴⁶ (show all 12)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	cellular	MP:0005384	10.11	RAD51 ESR1 PGR BRCA2 ATM CHEK2
2	embryo	MP:0005380	10.02	PGR RAD51 BRCA2 ESR1 ATM BRCA1
3	homeostasis/metabolism	MP:0005376	10.01	ESR1 FHIT PGR ERBB2 BRCA2 ATM
4	endocrine/exocrine gland	MP:0005379	10	PGR BRCA2 ESR1 ATM CHEK2 BRCA1
5	hematopoietic system	MP:0005397	9.98	ESR1 FHIT PGR BRCA1 BRCA2 ATM
6	immune system	MP:0005387	9.91	ESR1 FHIT PGR BRCA1 BRCA2 ATM
7	digestive/alimentary	MP:0005381	9.89	ESR1 FHIT BRCA1 ERBB2 BRCA2
8	integument	MP:0010771	9.87	FHIT PGR BRCA2 ESR1 ATM BRCA1
9	mortality/aging	MP:0010768	9.81	FHIT PGR RAD51 BRCA2 ESR1 ATM
10	limbs/digits/tail	MP:0005371	9.65	ESR1 PGR ERBB2 BRCA2 BRCA1
11	neoplasm	MP:0002006	9.56	FHIT PGR BRCA2 ESR1 ATM CHEK2
12	reproductive system	MP:0005389	9.1	ESR1 PGR BRCA1 ERBB2 BRCA2 ATM

Sources

Drugs & Therapeutics for Bilateral Breast Cancer

Drugs for Bilateral Breast Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Anastrozole

Approved, Investigational

Phase 3

120511-73-1

2187

Synonyms:

.alpha.,alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)

120511-73-1

2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)

2,2'-(5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)

2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)

2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)

2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile

a,a,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

AC1L1D49

AC-4234

alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

anastrazole

Anastrazole

Anastrole

Anastrozol

anastrozole

Anastrozole (JAN/USAN/INN)

Anastrozole [USAN:INN:BAN]

Arimidex

Arimidex (TN)

Arimidex (Zeneca)

Arimidex, Anastrozole

Asiolex

Astra brand of anastrozole

Astra brand OF anastrozole

AstraZeneca brand of anastrozole

AstraZeneca brand OF anastrozole

C08159

C090450

C17H19N5

CHEBI:2704

CHEMBL1399

CID2187

CPD000466301

D00960

DB01217

HMS2052M11

HMS2089N10

HSDB 7462

I06-0021

ICI D1033

ICI-D 1033

ICI-D1033

LS-29563

MLS000759396

MLS001424217

MolPort-005-933-078

NCGC00164619-01

NSC719344

S1188_Selleck

SAM001246525

SBB066057

SMR000466301

UNII-2Z07MYW1AZ

ZD 1033

ZD1033

ZD-1033

Zeneca brand of anastrozole

Zeneca brand OF anastrozole

Zeneca ZD 1033

ZINC00000941

α,α,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile

Exemestane

Approved, Investigational

Phase 3

107868-30-4

60198

Synonyms:

(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione

107868-30-4

6-Methylenandrosta-1,4-diene-3,17-dione

6-Methyleneandrosta-1,4-diene-3,17-dione

6-methylideneandrosta-1,4-diene-3,17-dione

AC1L1SRB

AC1Q6AAZ

AC-2171

Ambap107868-30-4

Aromasil

Aromasin

Aromasin (TN)

Aromasin, Exemestane

Aromasine

C056516

C08162

CHEBI:4953

CHEMBL1200374

CID60198

CPD000466314

Curator_000009

D00963

DB00990

Examestane

EXE

Exemestance

exemestane

Exemestane

EXEMESTANE

Exemestane (JAN/USP/INN)

Exemestane [USAN:INN:BAN]

Exemestano

Exemestano [INN-Spanish]

Exemestanum

Exemestanum [INN-Latin]

Fce 24304

FCE-24304

HMS2051J04

HSDB 7463

LS-19329

MLS000759419

MLS001424062

MolPort-003-847-343

Nikidess

NSC713563

Pfizer brand of exemestane

PNU-155971

S1196_Selleck

S1196_Sellek

SAM001246574

SMR000466314

UNII-NY22HMQ4BX

ZINC03973334

Tamoxifen

Approved

Phase 3

10540-29-1

2733526

Synonyms:

(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene

(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine

(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine

(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine

(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine

(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)

(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE

(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine

,citrate

10540-29-1

1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-b-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-Para-β-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-P-b-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1-P-β-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene

1ya4

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine

2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine

54965-24-1 (citrate)

AC1MBZ3R

apo-Tamox

Apo-Tamox

BIDD:ER0008

BIDD:GT0009

BIDD:PXR0003

BPBio1_000278

BRD-K93754473-001-02-9

BRD-K93754473-048-05-3

BSPBio_000252

BSPBio_001150

BSPBio_001982

C07108

C26H29NO

CCRIS 3275

CHEBI:41774

CHEMBL83

CID2733526

Citofen

Citrate, tamoxifen

cMAP_000044

Crisafeno

D08559

DB00675

Diemon

EINECS 234-118-0

Gen-tamoxifen

Gen-Tamoxifen

HMS1362J11

HMS1792J11

HMS1990J11

HMS2090N08

HSDB 6782

ICI 47699

ICI-46,474

ICI-47699

IDI1_000258

IDI1_002170

Istubol

Kessar

L024126

Lopac0_001203

LS-393

MLS001332535

MLS001332536

MolPort-003-850-384

NCGC00024928-01

NCGC00024928-03

NCGC00024928-04

NCGC00024928-05

NCGC00024928-07

NCGC00024928-08

NCGC00024928-09

NCGC00024928-12

nchembio.140-comp7

nchembio.76-comp1

nchembio732-comp3

Noltam

Nolvadex

Nolvadex-D

Nourytam

Novaldex

Novo-Tamoxifen

NSC727681

Oncomox

Pms-Tamoxifen

PMS-Tamoxifen

Prestwick2_000146

Prestwick3_000146

QTL1_000079

Retaxim

Savient brand OF tamoxifen citrate

SMR000059172

Soltamox

Spectrum5_001417

Spectrum5_002043

ST50511785

T5648_SIGMA

Tamizam

Tamofen

Tamone

Tamoplex (TN)

Tamoxasta

Tamoxen

tamoxifen

Tamoxifen

Tamoxifen (INN)

TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))

Tamoxifen (TN)

Tamoxifen (Z)

Tamoxifen [INN:BAN]

Tamoxifen and its salts

Tamoxifen citrate

Tamoxifen Citrate

Tamoxifene

Tamoxifène

Tamoxifene [INN-French]

Tamoxifeno

Tamoxifeno [INN-Spanish]

Tamoxifenum

Tamoxifenum [INN-Latin]

Tocris-0999

Tomaxithen

TRANS FORM OF TAMOXIFEN

trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine

trans-Tamoxifen

Trans-Tamoxifen

UNII-094ZI81Y45

UPCMLD-DP027

Valodex

Zemide

Zitazonium

Letrozole

Approved, Investigational

Phase 3

112809-51-5

3902

Synonyms:

1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole

1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole

112809-51-5

4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile

4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile

4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile

4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)

4,4'-(1H-1,2,4-Triazol-1-yl-methylene)-bis(benzonitrile)

4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile

4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile

4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-Benzonitrile Letrozole

4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile

4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile

AB00514009

AC-1193

AC1L1GYT

AKOS005145822

BIDD:GT0015

BIDD:PXR0130

Bio-0057

BPBio1_001331

BRD-K88789588-001-03-2

BSPBio_001209

C067431

C08163

C17H11N5

CAS-112809-51-5

CCRIS 8822

CGS 20267

CGS 20267, Femara, Piroxicam, Letrozole

CGS-20267

CHEBI:6413

CHEMBL1444

CID3902

CPD000466343

D00964

DB01006

FEM-345

Femara

Fémara

Femara (TN)

Femera

HMS1571M11

HMS2051E08

HMS2089L22

HSDB 7461

I06-0022

Letoval

Letrozol

letrozole

Letrozole (JAN/USP/INN)

Letrozole [USAN:INN]

LS-38788

MLS000759455

MLS001424038

MLS002584991

MolPort-003-848-373

NCGC00016973-01

NCGC00016973-02

Novartis brand OF letrozole

Novartis Brand of Letrozole

NSC719345

Prestwick0_001025

Prestwick1_001025

Prestwick2_001025

Prestwick3_001025

S1235_Selleck

SAM001246649

SMR000466343

SPBio_003070

TL8000371

UNII-7LKK855W8I

ZINC03778874

Citric Acid

Approved, Nutraceutical, Vet_approved

Phase 3

77-92-9

311

Synonyms:

2-Hydroxy-1,2,3-propanetricarboxylate

2-Hydroxy-1,2,3-propanetricarboxylic acid

2-Hydroxytricarballylate

2-Hydroxytricarballylic acid

3-Carboxy-3-hydroxypentane-1,5-dioate

3-Carboxy-3-hydroxypentane-1,5-dioic acid

Acid monohydrate, citric

Aciletten

Anhydrous citrate

Anhydrous citric acid

beta-Hydroxytricarballylate

beta-Hydroxytricarballylic acid

Chemfill

Citraclean

Citrate

Citretten

Citric acid monohydrate

Citric acid, anhydrous

Citric Acid, Anhydrous

Citro

Citronensaeure

Citronensäure

e 330

e330

H3Cit

Hydrocerol a

Kyselina citronova

Monohydrate, citric acid

Suby g

Uralyt u

uro-Trainer

Chelating Agents

Phase 3

Selective Estrogen Receptor Modulators

Phase 3

Steroid Synthesis Inhibitors

Phase 3

Hormone Antagonists

Phase 3

Hormones

Phase 3

Hormones, Hormone Substitutes, and Hormone Antagonists

Phase 3

Estrogen Antagonists

Phase 3

Estrogen Receptor Modulators

Phase 3

Estrogens

Phase 3

Anticoagulants

Phase 3

Aromatase Inhibitors

Phase 3

Bone Density Conservation Agents

Phase 3

Calcium, Dietary

Phase 3

Antineoplastic Agents, Hormonal

Phase 3

Citrate

Nutraceutical

Phase 3

Cyclophosphamide

Approved, Investigational

Phase 2

50-18-0, 6055-19-2

2907

Synonyms:

(-)-Cyclophosphamide

(+-)-Cyclophosphamide

(RS)-Cyclophosphamide

1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine

1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin

2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide

4-Hydroxy-cyclophosphan-mamophosphatide

50-18-0

60007-95-6

6055-19-2 (monohydrate)

75526-90-8

AC1L1EQQ

AI3-26198

Anhydrous cyclophosphamide

Anhydrous, cyclophosphamide

ASTA

Asta B 518

ASTA B518

B 518

B-518

bis(2-Chloroethyl)phosphami de cyclic propanolamide

bis(2-Chloroethyl)phosphamide cyclic propanolamide ester

Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester

BRN 0011744

BSPBio_002099

C 0768

C07888

C7H15Cl2N2O2P

CB 4564

CB-4564

CCRIS 188

CHEBI:4027

CHEMBL32520

CHEMBL88

Ciclofosfamida

Ciclofosfamida [INN-Spanish]

Ciclofosfamide

Ciclophosphamide

Ciclophosphamide [INN]

CID2907

Clafen

Claphene

CPA

CTX

Cycloblastin

Cyclophosphamid

cyclophosphamide

Cyclophosphamide

Cyclophosphamide (anhydrous form)

Cyclophosphamide (anhydrous)

Cyclophosphamide (INN)

Cyclophosphamide (TN)

Cyclophosphamide anhydrous

Cyclophosphamide monohydrate

Cyclophosphamide Monohydrate

Cyclophosphamide Sterile

Cyclophosphamide, (+-)-Isomer

Cyclophosphamide, (R)-isomer

Cyclophosphamide, (S)-isomer

Cyclophosphamides

Cyclophosphamidum

Cyclophosphamidum [INN-Latin]

Cyclophosphan

Cyclophosphane

Cyclophosphanum

Cyclophosphoramide

Cyclostin

Cyklofosfamid

Cyklofosfamid [Czech]

Cytophosphan

Cytophosphane

Cytoxan

Cytoxan (TN)

Cytoxan Lyoph

D,L-Cyclophosphamide

D07760

DB00531

DivK1c_000246

EINECS 200-015-4

Endoxan

Endoxan R

Endoxana

Endoxanal

Endoxan-Asta

Endoxane

Enduxan

EU-0100238

Genoxal

Hexadrin

HMS2090A12

HSDB 3047

IDI1_000246

KBio1_000246

KBio2_001338

KBio2_003906

KBio2_006474

KBio3_001319

KBioGR_000888

KBioSS_001338

Ledoxina

Lopac0_000238

Lopac-C-0768

LS-1302

LS-99787

Lyophilized Cytoxan

Mitoxan

MolPort-001-783-420

Monohydrate, cyclophosphamide

N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide

N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

NCGC00015209-01

NCGC00015209-03

NCGC00015209-06

NCGC00091741-02

NCGC00091741-03

NCI60_002097

NCI-C04900

Neosar

NINDS_000246

NSC 26271

NSC26271

NSC-26271

NSC273033

NSC273034

Occupation, cyclophosphamide exposure

Procytox

RCRA waste no. U058

Rcra waste number U058

Rcra Waste Number U058

Revimmune

S1217_Selleck

Semdoxan

Sendoxan

Senduxan

SK 20501

SPBio_001071

Spectrum_000858

Spectrum2_001146

Spectrum3_000370

Spectrum4_000304

Spectrum5_000795

STK177249

STOCK2S-91217

UNII-6UXW23996M

WLN: T6MPOTJ BO BN2G2G

Zyklophosphamid

Zyklophosphamid [German]

leucovorin

Approved, Nutraceutical

Phase 2

58-05-9

143 6006

Synonyms:

(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate

(6R,S)-5-Formyltetrahydrofolate

10-Formyl-7,8-dihydrofolate

10-Formyl-7,8-dihydrofolic acid

5 Formyltetrahydrofolate

5 Formyltetrahydropteroylglutamate

5-Formyl-5,6,7,8-tetrahydrofolate

5-Formyl-5,6,7,8-tetrahydrofolic acid

5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid

5-Formyltetrahydrofolate

5-formyltetrahydrofolic acid

5-Formyltetrahydrofolic acid

5-Formyltetrahydropteroylglutamate

5-Formyltetrahydropteroylglutamic acid

Acid, folinic

Acide folinique

Calcium citrovorum factor

Calcium folinate

Calcium leucovorin

Citrovorum factor

Factor, citrovorum

folinate

Folinate

Folinate, calcium

Folinic acid

Folinic acid calcium salt

Folinic acid calcium salt USP27

Folinic acid SF

Folinic acid-SF

L(-)-5-Formyl-5,6,7,8-tetrahydrofolate

L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid

Leucal

Leucovorin

Leucovorin calcium

Leucovorin folinic acid

Leucovorin, (D)-isomer

Leucovorin, (DL)-isomer

Leucovorin, (R)-isomer

Leucovorin, calcium

Leucovorin, calcium (1:1) salt

Leucovorin, calcium (1:1) salt, (DL)-isomer

Leucovorin, calcium (1:1) salt, pentahydrate

Leucovorin, monosodium salt

Leucovorinum

Leukovorin

Leukovorum

Levoleucovorin

L-leucovorin

L-Leucovorin

L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid

Monosodium salt leucovorin

N(5)-Formyltetrahydrofolate

N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid

N5-Formyl-5,6,7,8-tetrahydrofolate

N5-Formyl-5,6,7,8-tetrahydrofolic acid

N5-Formyltetrahydrofolate

N5-Formyltetrahydrofolic acid

Rescuvolin

Welcovorin

Wellcovorin

Folic Acid

Approved, Nutraceutical, Vet_approved

Phase 2

59-30-3

6037

Synonyms:

(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid

01769_FLUKA

2d0k

33609-88-0

36653-55-1 (mono-potassium salt)

59-30-3

6484-89-5 (mono-hydrochloride salt)

AC-11682

AC1L1LNX

Acfol (Spain)

Acide folique

Acide folique [INN-French]

Acido folico

Acido folico [INN-Spanish]

Acidum folicum

Acidum folicum [INN-Latin]

Acifolic

AI3-26387

AKOS000503224

Antianemia factor

Apo-Folic

ARONIS014410

b9, Vitamin

BIDD:ER0563

BIDD:GT0641

BIF0608

bmse000299

BPBio1_000654

BSPBio_000594

BSPBio_002338

C00504

C20H20N6O6

CAS-59-30-3

CCRIS 666

CHEBI:27470

CHEMBL1622

CID6037

CPD000471860

Cytofol

D00070

DB00158

DivK1c_000494

Dosfolat b activ

Dosfolat B activ

EINECS 200-419-0

F0043

F7876_SIAL

F7876_SIGMA

F8758_SIGMA

F8798_SIAL

F8890_SIGMA

Facid

Factor U

FOL

Folacid

Folacin

Folaemin

Folaemin [Netherlands]

Folan

Folasic (Australia)

Folate

Folbal

Folcidin

Folcidin (VAN)

Folcysteine

Foldine

Foldine [France]

Folettes

Foliamin

Folic

folic acid

Folic acid

Folic acid (JP15/USP/INN)

Folic acid (TN)

Folic acid [BAN:INN:JAN]

Folic acid [INN:BAN:JAN]

Folic acid dihydrate

Folic acid, (D)-isomer

Folic acid, (DL)-isomer

Folic acid, calcium salt (1:1)

Folic acid, monopotassium salt

Folic acid, monosodium salt

Folic acid, potassium salt

Folic acid, sodium salt

Folicet

Folicet (TN)

Folico

Folico (Italy)

Folina

Folina (Italy)

Folipac

Folsaeure

Folsan

Folsaure

Folsav

Folvite

Folvron

Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L

HMS1921D20

HMS2092N17

HMS501I16

HSDB 2002

IDI1_000494

Incafolic

InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s

KBio1_000494

KBio2_001861

KBio2_004429

KBio2_006997

KBio3_001558

KBioGR_002222

KBioSS_001861

Kyselina listova

Kyselina listova [Czech]

Liver lactobacillus casei factor

Liver Lactobacillus casei factor

LS-2157

Millafol

Mission prenatal

Mittafol

MLS001304016

MLS001335861

MolPort-004-285-551

N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid

N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid

N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid

N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid

N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid

N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate

N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid

N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid

NCGC00016265-01

NCGC00142391-01

nchembio.108-comp10

Nifolin

Nifolin [Denmark]

NINDS_000494

Novofolacid

Novofolacid [Canada]

N-Pteroyl-L-glutamate

N-Pteroyl-L-glutamic acid

NSC 3073

PGA

PGA (VAN)

Prestwick_230

Prestwick3_000627

PteGlu

Pteroylglutamate

Pteroylglutamic acid

Pteroyl-L-glutamate

Pteroyl-L-glutamic acid

Pteroyl-L-monoglutamate

Pteroyl-L-monoglutamic acid

Pteroylmonoglutamate

Pteroylmonoglutamic acid

SAM002264616

SDCCGMLS-0066738.P001

Serum Folate Level

SMP2_000137

SMR000471860

SPBio_001357

Spectrum_001381

SPECTRUM1502020

Spectrum2_001459

Spectrum3_000749

Spectrum4_001751

Spectrum5_000602

UNII-935E97BOY8

Usaf cb-13

Vitamin B11

Vitamin b9

Vitamin B9

Vitamin Bc

Vitamin BC

Vitamin be

Vitamin Be

Vitamin m

Vitamin M

Alkylating Agents

Phase 2

Micronutrients

Phase 2

Hematinics

Phase 2

Trace Elements

Phase 2

Vaccines

Phase 2

Vitamin B Complex

Phase 2

Vitamins

Phase 2

Immunosuppressive Agents

Phase 2

Antirheumatic Agents

Phase 2

Antineoplastic Agents, Alkylating

Phase 2

Folate

Nutraceutical

Phase 2

Vitamin B9

Nutraceutical

Phase 2

Acetaminophen

Approved

Not Applicable

103-90-2

1983

Synonyms:

4-(acetylamino)Phenol

4-(Acetylamino)phenol

4-acetamidophenol

4-Acetamidophenol

4-Acetaminophenol

4'-hydroxyacetanilide

4'-Hydroxyacetanilide

4-Hydroxyacetanilide

4-Hydroxyanilid kyseliny octove

A.F. anacin

Abenol

Abensanil

Abrol

Abrolet

AC1Q1KYJ

AC1Q1KYK

Acamol

Accu-tap

Accu-Tap

Acenol

Acephen

Acertol

Aceta elixir

Aceta Elixir

Aceta tablets

Aceta Tablets

Acetaco

Acetagesic

Acetalgin

Acetaminofen

acetaminofén

Acetaminophen

Acetaminophen uniserts

Acetaminophene

acétaminophène

Acetamol

Acetavance

Acetofen

Actamin

Actamin extra

Actamin super

Actifed plus

Actifed Plus

Actimol

Actimol chewable tablets

Actimol children's suspension

Actimol infants' suspension

Actimol junior strength caplets

Actron

Afebrin

Afebryl

Aferadol

Algesidal

Algina

Algomol

Algotropyl

Allay

alpha-Per

Alpiny

Alpinyl

Alvedon

Amadil

Aminofen

Aminofen max

Anacin

Anacin 3

Anacin-3

Anacin-3 extra strength

Anadin dla dzieci

Anaflon

Analter

Anapap

Andox

Anelix

Anexsia

Anexsia 10/660

Anexsia 5/325

Anexsia 7.5/325

Anexsia 7.5/650

Anhiba

Anoquan

Anti-algos

Antidol

Anuphen

Apacet

Apacet capsules

Apacet elixir

Apacet extra strength caplets

Apacet extra strength tablets

Apacet regular strength tablets

Apadon

Apamid

Apamide

APAP

a-Per

A-Per

Apitrelal

apo-Acetaminophen

Arfen

Arthralgen

Asetam

Asomal

Aspac

Aspirin free anacin maximum strength caplets

Aspirin free anacin maximum strength gel caplets

Aspirin free anacin maximum strength tablets

Aspirin-free anacin

Aspirin-free excedrin caplets

Asplin

Atasol

Atasol caplets

Atasol drops

Atasol forte caplets

Atasol forte tablets

Atasol oral solution

Atasol tablets

Atralidon

Babikan

Bacetamol

Bancap

Bancap HC

Banesin

Bayer Select

Bayer select allergy-sinus

Bayer select head cold

Bayer select headache pain

Bayer select maximum strength headache pain relief formula

Bayer select menstrual multi-symptom

Bayer select sinus pain relief

Benmyo

Ben-u-ron

Bickie-mol

Biocetamol

Bucet

Butalbital

Butapap

Cadafen

Calapol

Calmanticold

Calonal

Calpol

Capital

Capital with codeine

Captin

Causalon

CCRIS 3

Cefalex

Cetadol

CHEBI:46195

Children'S acetaminophen elixir drops

Children'S acetaminophen oral solution

Children'S tylenol chewable

Claradol codeine

Clixodyne

Codabrol

COD-Acamol forte

Codalgin

Codapane

Codicet

Codisal

Codisal forte

Codoliprane

Codral pain relief

Cofamol

Co-Gesic

CO-Gesic

Conacetol

Contac cough & sore throat formula

Contra-schmerz P

Coricidin

Coricidin D

Coricidin sinus

Cosutone

Croix blanche

Cuponol

Curadon

Curpol

Custodial

D oliprane

Dafalgan

Dapa

Dapa X-S

Darocet

Darvocet

Darvocet-N 50

Datril

Datril extra-strength

Daygrip

Demilets

Deminofen

Democyl

Demogripal

Desfebre

Dhamol

DHC Plus

Dial-a-gesic

Dial-alpha-gesic

Dimindol

Dirox

Disprol

Dolcor

Dolefin

Dolegrippin

Dolene ap-65

Dolene AP-65

Dolgesic

Doliprane

Dolko

Dolofugin

Doloreduct

Dolorfug

Dolorol forte

Dolorstop

Dolotec

Dolprone

Dol-stop

Dorocoff

Dresan

Dristan cold no drowsiness

Dristancito

Drixoral Plus

Duaneo

Dularin

Duorol

Duracetamol

Duradyne DHC

Durapan

Dymadon

Dymadon co

Dymadon Co

Dymadon forte

Dypap

Ecosetol

Elixodyne

Empracet

Endecon

Enelfa

Eneril

Esgic

Esgic-plus

Eu-med

Eu-Med

Excedrin

Excedrin caplets

Excedrin extra strength caplets

Excipain

Exdol

Exdol strong

Fanalgic

Farmadol

Febranine

Febrectal

Febrectol

Febrex

Febricet

Febridol

Febrilix

Febrin

Febrinol

febro-Gesic

Febro-Gesic

Febrolin

Femcet

Fendon

Fensum

Fepanil

Fever All

Feverall

Feverall junior strength

Feverall sprinkle caps junior strength

Fevor

Finimal

Finiweh

Fioricet

Fluparmol

Fortalidon P

Freka-cetamol

Gattaphen T

Gelocatil

Geluprane

Genapap

Genapap children's elixir

Genapap children's tablets

Genapap extra strength caplets

Genapap extra strength tablets

Genapap regular strength tablets

Genebs

Genebs extra strength caplets

Genebs regular strength tablets

Genebs X-tra

Geralgine-P

Gripin bebe

Gripin Bebe

Grippostad

Gynospasmine

Hedex

Helon N

Homoolan

Hycomine compound

Hydrocet

Hy-phen

Hy-Phen

Ildamol

Inalgex

Infadrops

Infants' feverall

Influbene N

Injectapap

Intensin

Janupap

Jin Gang

Junior disprol

Kataprin

KBio1_000660

Kinder finimal

Korum

Kratofin simplex

L024125

Labamol

Lekadol

Lemgrip

Lemsip

Lestemp

Liqiprine

Liquagesic

Liquigesic co

Liquiprin

Liquiprin children's elixir

Liquiprin infants" drops

Lonarid

Lonarid mono

Lonarid Mono

Lorcet-HD

Lortab

Lupocet

Lyteca

Lyteca syrup

Lyteca Syrup

Magnidol

Malex N

Malgis

Malidens

Maxadol

Medigesic plus

Medinol paediatric

Medocodene

Melabon infantil

Mexalen

Midol maximum strength

Midol PM night time formula

Midol regular strength

Midol teen formula

Migraleve yellow

Minafen

Minoset

Miralgin

Momentum

mono Praecimed

Multin

N-(4-Hydroxyphenyl)acetamide

N-Acetyl-4-aminophenol

N-acetyl-p-aminophenol

N-Acetyl-P-aminophenol

Naldegesic

NAPA

Napafen

Napap

Naprinol

NCX 701

Nealgyl

Nebs

NEBS

NeoCitran

Neodol

Neodolito

neo-Fepramol

Neo-Fepramol

Neopap

Neotrend

Neuridon

New cortal for children

NilnOcen

Nina

Nobedon

Nodolex

NO-Febril

Noral

Norcet

Norco

NSC3991

O-Acetaminophenol

Ofirmev

Oltyl

Oralgan

Oraphen-PD

Ortensan

Oxycet

Oxycocet

Oxycodone 2.5/apap 500

Oxycodone 5/apap 500

P-(acetylamino)Phenol

Paceco

Pacemo

Pacemol

Pacet

p-acetamidophenol

P-Acetamidophenol

p-acetaminophenol

P-Acetaminophenol

p-Acetylaminophenol

P-Acetylaminophenol

Pacimol

Paedialgon

Paedol

Painex

Paldesic

Pamol

Panacete

Panadeine

Panadeine co

Panadeine Co

Panadiene

panado-Co

Panado-Co

panado-co Caplets

Panadol

Panadol extra strength

Panadol junior strength caplets

Panadol maximum strength caplets

Panadol maximum strength tablets

Panale ve

Panaleve

Panamax

Panasorb

Panasorbe

Panets

Panex

Panodil

Panofen

Pantalgin

Papa-Deine

Papa-deine #3

Papa-deine #4

Paracemol

Paracenol

Paracet

Paracetamol

Paracétamol

Paracetamol al

Paracetamol antipanin P

Paracetamol basics

Paracetamol BC

Paracetamol DC

Paracetamol dr. schmidgall

Paracetamol fecofar

Paracetamol genericon

Paracetamol hanseler

Paracetamol harkley

Paracetamol heumann

Paracetamol hexal

Paracetamol italfarmaco

Paracetamol nycomed

Paracetamol PB

Paracetamol raffo

Paracetamol ratiopharm

Paracetamol rosch

Paracetamol saar

Paracetamol smithkline beecham

Paracetamol stada

Paracetamol von CT

Paracetamol winthrop

Paracetamole

Paracetamolo

Paracetamolum

Paracetanol

Paracetol

Paracin

Paracod

Paracodol

Parador

Paradrops

Parakapton

Parake

Paralen

Paralief

Paralink

Paralyoc

Paramol

Paramolan

Paranox

Parapan

Parasedol

Parasin

Paraspen

Para-suppo

Para-Suppo

Para-tabs

Parcetol

Parelan

Parmol

Parogal

Paroma

Pasolind

Pasolind N

PCM Paracetamol lichtenstein

Pediapirin

Pediatrix

Pedric

Percocet

Percocet-5

Percocet-demi

Percogesic with codeine

Perdolan mono

Perfalgan

Pe-tam

Pe-Tam

Phenaphen

Phenaphen caplets

Phenaphen Caplets

Phenaphen w/codeine

Phendon

Phenipirin

Phogoglandin

Phrenilin

Phrenilin forte

Phrenilin Forte

p-hydroxy-acetanilid

p-hydroxyacetanilide

P-Hydroxyacetanilide

p-hydroxyphenolacetamide

P-Hydroxyphenolacetamide

Pinex

Piramin

Pirinasol

Plicet

Polmofen

Predimol

Predualito

Prestwick_13

Prodol

Prompt

Prontina

Propacet

Propacet 100

Proval #3

Puernol

Pulmofen

Pyregesic-C

Pyrigesic

Pyrinazine

Pyromed

Quiet world

Redutemp

Reliv

Remedol

Rhinex D-lay tablets

Rivalgyl

Robigesic

Robitussin night relief

Rockamol plus

Rounox

Roxicet

Roxicet 5/500

Roxilox

RubieMol

Rubophen

Rupemol

Salzone

Sanicet

Sanicopyrine

Scanol

Scentalgyl

Scherzatabletten rezeptur 534

Schmerzex

Sedalito

Sedapap

Semolacin

Servigesic

Seskamol

Setakop

Setamol

Setol

Sifenol

Sinaspril

Sinedol

Sine-OFF sinus medicine caplets

Sinmol

Sinubid

SK-Apap

Snaplets-FR

Spalt fur die nacht

Spalt N

SPBio_002836

ST Joseph aspirin-free

ST Joseph aspirin-free for children

St. joseph cold tablets for children

St. joseph fever reducer

St. Joseph Fever Reducer

Stanback

Stopain

Sudafed severe cold formula

Sudafed sinus

Sunetheton

Supac

Supadol mono

Supofen

Suppap

Suppap-120

Suppap-325

Suppap-650

Supramol-m

Supramol-M

Synalgos-Dc-A

Synalgos-DC-a

Tabalgin

Tachiprina

Talacen

Tapanol

Tapanol extra strength caplets

Tapanol extra strength tablets

Tapar

Tavist allergy/sinus/headache

Tavist Allergy/Sinus/Headache

Tazamol

Temlo

Tempanal

Tempra

Tempra caplets

Tempra chewable tablets

Tempra d.s

Tempra drops

Tempra syrup

Tencon

Termacet

Termalgin

Termalgine

Termofren

TheraFlu

Tibinide

Tibizide

Tiffy

Tisin

Tisiodrazida

Titralgan

Tizide

Tocris-1706

Toximer P

Tralgon

Treupel mon

Treupel N

Treuphadol

Triad

Triaminic sore throat formula

Triaprin

Tricoton

Tussapap

Ty lenol

Tycolet

TYL

Tylenol

Tylenol (TN)

Tylenol allergy sinus

Tylenol arthritis extended relief

Tylenol caplets

Tylenol children's chewable tablets

Tylenol children's elixir

Tylenol children's suspension liquid

Tylenol drops

Tylenol elixir

Tylenol extra strength adult liquid pain reliever

Tylenol extra strength caplets

Tylenol extra strength gelcaps

Tylenol extra strength tablets

Tylenol gelcaps

Tylenol infants drops

Tylenol infants" suspension drops

Tylenol junior strength caplets

Tylenol junior strength chewable tablets

Tylenol regular strength caplets

Tylenol regular strength tablets

Tylenol tablets

Tylex

Tylex CD

Tylol

Tylox

Tylox-325

Tymol

Ultracet

Upsanol

Utragin

Valadol

Valgesic

Valorin

Valorin extra

Valorin Extra

Vanquish

Veralgina

Vermidon

Verpol

Viclor richet

Vicodin

Vicodin es

Vicodin HP

Vips

Viruflu

Vivimed

Volpan

Wygesic

Zatinol

Zolben

Analgesics

Not Applicable

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer	Active, not recruiting	NCT01272037	Phase 3	Anastrozole;Exemestane;Letrozole;Systemic Chemotherapy;Tamoxifen Citrate
2	Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer	Recruiting	NCT03012100	Phase 2	Cyclophosphamide
3	Pre-operative Magnetic Resonance Imaging (MRI) in Young Breast Cancer Patients	Unknown status	NCT00801476	Not Applicable
4	EMG at Performing ULTN 1 in Breast Cancer Patients	Completed	NCT02599467	Not Applicable
5	Study of Radiation Exposure and Bilateral Breast Cancer	Active, not recruiting	NCT00903591
6	Genetic Counseling for Breast Cancer Survivors (GC for BC)	Active, not recruiting	NCT02451735	Not Applicable

Search NIH Clinical Center for Bilateral Breast Cancer

Sources

Genetic Tests for Bilateral Breast Cancer

Genetic tests related to Bilateral Breast Cancer:

#	Genetic test	Affiliating Genes
1	Bilateral Breast Carcinoma ²⁹

Sources

Anatomical Context for Bilateral Breast Cancer

MalaCards organs/tissues related to Bilateral Breast Cancer:

⁴¹

Breast, Bone, Prostate, Lung, Testes, Pituitary, Cervix

Sources

Publications for Bilateral Breast Cancer

Articles related to Bilateral Breast Cancer:

(show top 50) (show all 224)

#	Title	Authors	Year
1	Sequential Sentinel Node Scintigraphy With Planar and SPECT/CT Images Revealed Contralateral Drainage From Ipsilateral Breast Tumor Relapse in a Patient With Bilateral Breast Cancer. ( 29659396 )	Koizumi M....Miyagi Y.	2018
2	Including internal mammary lymph nodes in radiation therapy for synchronous bilateral breast cancer: an international survey of treatment technique and clinical priorities. ( 29869775 )	Roumeliotis M....Quirk S.	2018
3	Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature. ( 29475749 )	DeFazio M.V....Willey S.C.	2018
4	Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer. ( 29315233 )	Callari M....Cappelletti V.	2018
5	First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer. ( 28707988 )	Wadasadawala T....Sarin R.	2017
6	A novel germline TP53 mutation p.Pro190Arg detected in a patient with lung and bilateral breast cancers. ( 28499267 )	KrzeA9niak M....Rusin M.	2017
7	Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome. ( 28139434 )	Denu R.A....Burkard M.E.	2017
8	Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population. ( 29254601 )	Wadasadawala T....Sarin R.	2017
9	Bilateral Breast Cancer After Prophylactic Bilateral Pulmonary Irradiation. ( 28272005 )	El Meddeb H.A....Bouaouina N.	2017
10	Gastric metastasis of bilateral breast cancer. ( 28280631 )	Jmour O....Benna F.	2017
11	pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials. ( 28063331 )	Reinisch M....Loibl S.	2017
12	Synchronous Bilateral Breast Cancer With Discordant Histology. ( 28412779 )	Copur M.S....Clark D.	2017
13	Treatment of bilateral breast cancer and regional nodes using an opposed lateral beam arrangement. ( 28867548 )	Farooqi A.S....Shaitelman S.F.	2017
14	Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost. ( 28224401 )	Fiorentino A....Alongi F.	2017
15	Bilateral breast keloids in an elderly woman associated with bilateral breast cancers and high concentration of serum tumor growth factor-I^. ( 29098727 )	Sakaguchi M....Oka M.	2017
16	Bilateral Breast Cancer with Neurofibromatosis Type 1 Patient: Case Report. ( 29082380 )	Dursun D....Olgun N.	2017
17	PALB2 mutation in a woman with bilateral breast cancer: A case report. ( 28413668 )	Nakagomi H....Omata M.	2017
18	Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer. ( 26855441 )	Almasi-Sperling V....Sagban T.A.	2016
19	Bilateral breast cancer resection performed under the bilateral transversus thoracic muscle plane block. ( 27555202 )	Ueshima H....Otake H.	2016
20	Image-guided intensity-modulated radiotherapy for refractory bilateral breast cancer in a patient with extensive cutaneous metastasis in the chest and abdominal walls. ( 27284253 )	Lu Y.F....Hsieh C.H.	2016
21	Unilateral Arm Urticaria Presenting as a Paraneoplastic Manifestation of Metachronous Bilateral Breast Cancer. ( 26933416 )	Kasi P.M....Haddad T.C.	2016
22	BILATERAL BREAST CANCER: DIAGNOSIS AND PROGNOSIS. ( 27483711 )	Ursaru M....Negru D.	2016
23	Helical tomotherapy for bilateral breast cancer: Clinical experience. ( 27253152 )	Kaidar-Person O....Marks L.B.	2016
24	Challenges of treating incidental synchronous bilateral breast cancer with differing tumour biology. ( 27539136 )	Esclovon J.W....Misra S.	2016
25	Co-existence of a giant cell tumour of the tendon sheath and schwannoma in a patient with bilateral breast cancer: A potential cause of false positive findings in (18)F-FDG PET/CT studies. ( 27329560 )	Ortega Candil A....Carreras Delgado J.L.	2016
26	Disease evolution and heterogeneity in bilateral breast cancer. ( 27904775 )	Fountzilas E....Fountzilas G.	2016
27	Metabolic flare phenomenon on 18 fluoride-fluorodeoxy glucose positron emission tomography-computed tomography scans in a patient with bilateral breast cancer treated with second-line chemotherapy and bevacizumab. ( 25829734 )	Balasubramanian Harisankar C.N....John J.	2015
28	Bilateral breast cancer, synchronous and metachronous; differences and outcome. ( 26268697 )	Jobsen J.J....Struikmans H.	2015
29	A case of synchronous multiple bilateral breast cancer after breast augmentation. ( 26722625 )	Yamamoto S....Matsubara Y.	2015
30	Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer. ( 26399280 )	Jobsen J.J....Struikmans H.	2015
31	Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? ( 26399842 )	Molinelli E....Offidani A.	2015
32	Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors. ( 25735321 )	Ibrahim N.Y....Darwish D.O.	2015
33	Bilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: A case report. ( 26137129 )	Zhao Y....Zhao X.	2015
34	Surgical management for early-stage bilateral breast cancer patients in china. ( 25874699 )	Chen J.J....Wu J.	2015
35	Breast-Conserving Surgery in Bilateral Breast Cancer. ( 26265365 )	O'Brien J.A....Gemignani M.L.	2015
36	Use of tomotherapy in treatment of synchronous bilateral breast cancer: dosimetric comparison study. ( 25605345 )	Wadasadawala T....Phurailatpam R.	2015
37	Multifocal Bilateral Breast Cancer and Breast Follicular Lymphoma: A Simple Coincidence? ( 26472982 )	Michalinos A....Kontos M.	2015
38	Bilateral breast cancer with a unilateral carcinoma within a fibroadenoma: A case report. ( 26622700 )	Zheng H....Qi C.	2015
39	Primary Squamous Cell Carcinoma of the Breast After Cured Bilateral Breast Cancer. ( 25398815 )	Porzio R....Cavanna L.	2014
40	Primary synchronous bilateral breast cancer. ( 25494117 )	Krishnappa R....Deshmane V.	2014
41	Morphoimmunohistochemical characteristics of synchronous bilateral breast cancer. ( 25257431 )	Todorov S.S....Nepomnyashchikh L.M.	2014
42	Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer. ( 25112434 )	Singer C.F....Narod S.A.	2014
43	A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors. ( 24736632 )	Chen J.J....Wu J.	2014
44	A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer. ( 24498881 )	Pradella L.M....Turchetti D.	2014
45	Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies. ( 25007962 )	Holm M....Kroman N.	2014
46	Periductal stromal tumor of the breast with synchronous bilateral breast cancer. ( 24982380 )	Ki S.Y....Shin S.H.	2014
47	A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case report. ( 24533645 )	Kashiwagi S....Hirakawa K.	2014
48	A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character. ( 23875131 )	Hayashi M....Iwase H.	2013
49	Synchronous bilateral breast cancer in a male. ( 24319497 )	Rubio HernA!ndez M.C....Aleaga Z.G.	2013
50	The molecular and clinicopathologic characteristics of bilateral breast cancer. ( 24005135 )	Chen S.F....Zhang G.J.	2013

Sources

Genes for Bilateral Breast Cancer

Genes related to Bilateral Breast Cancer (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	BRCA1	BRCA1, DNA Repair Associated	Protein Coding	36.18	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11556836 10573018 17557253 (more) 19372713 8723683 15319244 10737987 9145677 19629752 8281142 19736894 19153073 11802208 11389159 11149425 20104584 10188893 19649703 16331614 12151349 9333265 7627958 11130383 19127556 19393826
2	BRCA2	BRCA2, DNA Repair Associated	Protein Coding	36.16	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11556836 10573018 19649703 (more) 19372713 15319244 19127556 11793480 10699917 11389159 19153073 11802208 11149425 20104584 10188893 16331614 19288190 11130383 19698031
3	ATM	ATM Serine/Threonine Kinase	Protein Coding	30.41	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	19153073 12673797 14562025 (more) 15756685 18264724
4	CHEK2	Checkpoint Kinase 2	Protein Coding	30.27	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	19372713
5	RAD51	RAD51 Recombinase	Protein Coding	25.25	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	17666788 10807537
6	FHIT	Fragile Histidine Triad	Protein Coding	25.24	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	9157994
7	PGR	Progesterone Receptor	Protein Coding	22.7	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : DISEASES inferred (show sections)	7651928
8	ERBB2	Erb-B2 Receptor Tyrosine Kinase 2	Protein Coding	22.7	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
9	ESR1	Estrogen Receptor 1	Protein Coding	21.3	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : DISEASES inferred (show sections)	1663803 15941968 19153073

Sources

Variations for Bilateral Breast Cancer

Sources

Expression for Bilateral Breast Cancer

Search GEO for disease gene expression data for Bilateral Breast Cancer.

Sources

Pathways for Bilateral Breast Cancer

Pathways related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

(show all 35)

#	Super pathways	Score	Top Affiliating Genes
1	Gene Expression ⁶⁶ Show member pathways Generic Transcription Pathway ⁶⁶	13.57	ATM BRCA1 CHEK2 ERBB2 ESR1 PGR
2	Cell Cycle, Mitotic ⁶⁶ Show member pathways Cell Cycle ⁶⁶ M Phase ⁶⁶	13.2	ATM BRCA1 BRCA2 CHEK2 RAD51
3	DNA Double-Strand Break Repair ⁶⁶ Show member pathways Chk1/Chk2(Cds1) mediated inactivation of Cyclin B-Cdk1 complex ⁶⁶ DNA damage_DNA-damage-induced responses ²² DNA Repair ⁶⁶ G2/M DNA damage checkpoint ⁶⁶ HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA) ⁶⁶ HDR through MMEJ (alt-NHEJ) ⁶⁶ Homology Directed Repair ⁶⁶ Non-homologous end joining ¹ Non-homologous end-joining ³⁷ Processing of DNA double-strand break ends ⁶⁶	13.01	ATM BRCA1 BRCA2 CHEK2 RAD51
4	TCR Signaling (Qiagen) ⁶⁴ Show member pathways Fc-EpsilonRI Pathway ⁶⁴ PDGF Pathway ⁶⁴ PKC-Theta Pathway ⁶⁴ TCR Signaling ⁶⁴	12.74	ATM BRCA1 BRCA2 CHEK2 RAD51
5	Pathways in cancer ³⁷	12.64	BRCA2 ERBB2 ESR1 RAD51
6	Gastric cancer ³⁷ Show member pathways Breast cancer ³⁷ Hepatocellular carcinoma ³⁷	12.54	BRCA1 BRCA2 ERBB2 ESR1 PGR
7	Glioma ³⁷ Show member pathways EGFR tyrosine kinase inhibitor resistance ³⁷ Endocrine resistance ³⁷ Melanoma ³⁷ Non-small cell lung cancer ³⁷ Signaling Pathways in Glioblastoma ¹	12.4	ATM BRCA1 BRCA2 ERBB2 ESR1 FHIT
8	Meiosis ⁶⁶ Show member pathways Meiotic recombination ⁶⁶ Meiotic synapsis ⁶⁶	12.35	ATM BRCA1 BRCA2 RAD51
9	DNA Damage ⁴	12.27	ATM BRCA1 BRCA2 CHEK2 RAD51
10	Apoptosis Pathway ⁷² Show member pathways Akt Pathway ⁷² NF-kappaB Pathway ⁷²	12.25	ATM CHEK2 ERBB2
11	Chks in Checkpoint Regulation ⁶⁴ Show member pathways DNA Repair Mechanisms ⁶⁴ Estrogen-mediated S-Phase Entry ⁶⁴ G2-M Phase Transition ⁶⁴ Parkinson's Disease Pathway ⁶⁴ SREBP Proteolysis ⁶⁴	12.24	ATM BRCA1 BRCA2 CHEK2 ESR1 RAD51
12	DNA Damage Response ¹ Show member pathways miRNA Regulation of DNA Damage Response ¹ p53 signaling pathway ³⁷	12.23	ATM BRCA1 CHEK2 RAD51
13	DNA Double Strand Break Response ⁶⁶ Show member pathways Nonhomologous End-Joining (NHEJ) ⁶⁶ Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks ⁶⁶ Sensing of DNA Double Strand Breaks ⁶⁶	12.18	ATM BRCA1 CHEK2
14	Homologous DNA Pairing and Strand Exchange ⁶⁶ Show member pathways ATR Signaling ¹ HDR through Homologous Recombination (HRR) ⁶⁶ HDR through Single Strand Annealing (SSA) ⁶⁶ Presynaptic phase of homologous DNA pairing and strand exchange ⁶⁶	12.14	ATM BRCA1 BRCA2 RAD51
15	p53 Signaling ⁶⁴ Show member pathways p53 Pathway ⁶⁷	12.08	ATM BRCA1 CHEK2
16	Cell cycle Role of SCF complex in cell cycle regulation ²² Show member pathways Cell cycle ESR1 regulation of G1/S transition ²² Cell cycle Regulation of G1/S transition (part 1) ²² Immune response MIF-JAB1 signaling ²²	12.06	BRCA1 CHEK2 ESR1 PGR
17	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) ⁶⁶ Show member pathways Homologous recombination ³⁷ Homologous recombination ¹ Resolution of D-Loop Structures ⁶⁶ Resolution of D-loop Structures through Holliday Junction Intermediates ⁶⁶	11.94	ATM BRCA1 BRCA2 RAD51
18	Signaling by ERBB4 ⁶⁶ Show member pathways Downregulation of ERBB4 signaling ⁶⁶ ErbB4 signaling events ¹ Nuclear signaling by ERBB4 ⁶⁶	11.81	ERBB2 ESR1 PGR
19	Fanconi anemia pathway ⁶⁶ ³⁷	11.74	BRCA1 BRCA2 RAD51
20	Platinum drug resistance ³⁷	11.62	ATM BRCA1 ERBB2
21	ATM Pathway ⁶⁴ Show member pathways ATM Signaling Pathway ¹	11.61	ATM BRCA1 CHEK2 RAD51
22	Pathways Affected in Adenoid Cystic Carcinoma ¹	11.44	ATM BRCA1 CHEK2 ERBB2
23	Integrated Cancer Pathway ¹	11.39	ATM BRCA1 CHEK2
24	DNA damage_ATM/ATR regulation of G1/S checkpoint ²²	11.34	ATM BRCA1 CHEK2
25	ATM Signaling Network in Development and Disease ¹	11.33	ATM CHEK2
26	FOXA1 transcription factor network ¹ Show member pathways FOXA transcription factor networks ¹	11.32	BRCA1 ESR1
27	Cell cycle Role of 14-3-3 proteins in cell cycle regulation ²² Show member pathways 14-3-3 and Cell Cycle Regulation ⁶⁴	11.31	ATM CHEK2
28	Integrated Breast Cancer Pathway ¹	11.29	ATM BRCA1 BRCA2 CHEK2 ESR1 RAD51
29	BRCA1 Pathway ⁶⁴ Show member pathways Fanconi's Anaemia Pathway ⁶⁴	11.27	ATM BRCA1 BRCA2 CHEK2 RAD51
30	FOXM1 transcription factor network ¹	11.24	BRCA2 CHEK2 ESR1
31	GADD45 Pathway ⁶⁴	11.14	ATM BRCA1
32	Ovarian Infertility Genes ¹	11.14	ATM PGR
33	BARD1 signaling events ¹	11.07	ATM BRCA1 RAD51
34	Gemtuzumab ozogamicin Pathway, Pharmacokinetics/Pharmacodynamics ⁶¹	10.98	ATM CHEK2
35	DNA Damage Induced 14-3-3Sigma Signaling ⁶⁴	10.89	ATM BRCA1

Sources

GO Terms for Bilateral Breast Cancer

Cellular components related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	nucleoplasm	GO:0005654	9.8	ATM BRCA1 BRCA2 CHEK2 ESR1 PGR
2	protein-containing complex	GO:0032991	9.62	BRCA1 BRCA2 ESR1 RAD51
3	nucleus	GO:0005634	9.61	ATM BRCA1 BRCA2 CHEK2 ERBB2 ESR1
4	condensed nuclear chromosome	GO:0000794	9.4	BRCA1 RAD51
5	condensed chromosome	GO:0000793	9.37	BRCA1 RAD51
6	nuclear chromosome, telomeric region	GO:0000784	9.33	ATM BRCA2 RAD51
7	lateral element	GO:0000800	8.8	BRCA1 BRCA2 RAD51

Biological processes related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

(show all 31)

#	Name	GO ID	Score	Top Affiliating Genes
1	apoptotic process	GO:0006915	9.95	ATM BRCA1 CHEK2 FHIT
2	cell cycle	GO:0007049	9.93	ATM BRCA1 BRCA2 CHEK2
3	positive regulation of transcription, DNA-templated	GO:0045893	9.91	BRCA1 BRCA2 CHEK2 ESR1
4	cellular response to DNA damage stimulus	GO:0006974	9.83	ATM BRCA1 BRCA2 CHEK2 RAD51
5	regulation of apoptotic process	GO:0042981	9.81	ATM BRCA1 CHEK2 ESR1
6	protein autophosphorylation	GO:0046777	9.77	ATM CHEK2 ERBB2
7	DNA repair	GO:0006281	9.77	ATM BRCA1 BRCA2 CHEK2 RAD51
8	regulation of signal transduction by p53 class mediator	GO:1901796	9.76	ATM BRCA1 CHEK2
9	DNA recombination	GO:0006310	9.73	BRCA1 BRCA2 RAD51
10	double-strand break repair	GO:0006302	9.67	BRCA1 BRCA2 CHEK2
11	negative regulation of G0 to G1 transition	GO:0070317	9.65	BRCA1 RAD51
12	reciprocal meiotic recombination	GO:0007131	9.64	ATM RAD51
13	response to gamma radiation	GO:0010332	9.63	BRCA2 CHEK2
14	response to ionizing radiation	GO:0010212	9.63	ATM BRCA1 RAD51
15	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	GO:0042771	9.62	BRCA2 CHEK2
16	cellular response to gamma radiation	GO:0071480	9.62	ATM CHEK2
17	female gonad development	GO:0008585	9.61	ATM BRCA2
18	DNA double-strand break processing	GO:0000729	9.59	ATM BRCA1
19	replicative senescence	GO:0090399	9.58	ATM CHEK2
20	telomere maintenance via recombination	GO:0000722	9.57	BRCA2 RAD51
21	double-strand break repair via homologous recombination	GO:0000724	9.56	ATM BRCA1 BRCA2 RAD51
22	chromosome organization involved in meiotic cell cycle	GO:0070192	9.55	ATM RAD51
23	DNA damage induced protein phosphorylation	GO:0006975	9.52	ATM CHEK2
24	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	GO:0006978	9.5	BRCA1 BRCA2 CHEK2
25	chordate embryonic development	GO:0043009	9.48	BRCA1 BRCA2
26	intrinsic apoptotic signaling pathway in response to DNA damage	GO:0008630	9.46	ATM BRCA1 BRCA2 CHEK2
27	mitotic recombination-dependent replication fork processing	GO:1990426	9.4	BRCA2 RAD51
28	DNA synthesis involved in DNA repair	GO:0000731	9.26	ATM BRCA1 BRCA2 RAD51
29	strand displacement	GO:0000732	8.92	ATM BRCA1 BRCA2 RAD51
30	transcription, DNA-templated	GO:0006351	10.11	BRCA1 CHEK2 ERBB2 ESR1 FHIT PGR
31	regulation of transcription, DNA-templated	GO:0006355	10.08	BRCA1 BRCA2 CHEK2 ERBB2 ESR1 FHIT

Molecular functions related to Bilateral Breast Cancer according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	DNA binding	GO:0003677	9.73	ATM BRCA1 BRCA2 ESR1 PGR RAD51
2	nuclear receptor activity	GO:0004879	9.37	ESR1 PGR
3	nucleotide binding	GO:0000166	9.35	ATM CHEK2 ERBB2 FHIT RAD51
4	protein C-terminus binding	GO:0008022	9.33	BRCA2 ERBB2 RAD51
5	steroid binding	GO:0005496	9.32	ESR1 PGR
6	identical protein binding	GO:0042802	9.17	BRCA2 CHEK2 ERBB2 ESR1 FHIT PGR

Sources

Sources for Bilateral Breast Cancer

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia